已收盘 02-06 16:00:00 美东时间
+0.300
+3.82%
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
Goldman Sachs analyst Caitlin Burrows maintains Hudson Pacific Properties (NYSE:HPP) with a Neutral and lowers the price target from $16.5 to $14.5.
01-30 01:02
The most oversold stocks in the real estate sector presents an opportunity to b...
01-27 21:01
The most oversold stocks in the real estate sector presents an opportunity to b...
01-12 19:41
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
01-12 14:09
BMO Capital analyst John Kim downgrades Hudson Pacific Properties (NYSE:HPP) from Outperform to Market Perform and lowers the price target from $16 to $11.
01-09 20:12
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从47美元升至48美元;BTIG:维持Hudson Pacific Properties"买入"评级,目标价从4.75美元升至26美元
01-05 13:52
As widely expected, returns across real estate subsectors varied significantly in 2025. While the S&P 500 real estate sector ended the year in red against the broader S&P 500’s ~16% gain, health care ...
01-04 01:26
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-02 21:26
BTIG analyst Thomas Catherwood maintains Hudson Pacific Properties (NYSE:HPP) with a Buy and raises the price target from $4.75 to $26.
01-02 17:45